{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:44Z","timestamp":1792806284917,"version":"4.5.0"},"reference-count":39,"publisher":"Keio Journal of Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med."],"published-print":{"date-parts":[[2011]]},"DOI":"10.2302\/kjm.60.82","type":"journal-article","created":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T11:55:40Z","timestamp":1317383740000},"page":"82-89","source":"Crossref","is-referenced-by-count":103,"title":["Neuropeptide Effects in the Trigeminal System: Pathophysiology and Clinical Relevance in Migraine"],"prefix":"10.2302","volume":"60","author":[{"given":"Karl","family":"Messlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J. M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen K.","family":"Lennerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1.Brain SD, Cox HM: Neuropeptides and their receptors: Innovative science providing novel therapeutic targets. Br J Pharmacol2006; <b>147<\/b>(Suppl 1): S202-S211.","DOI":"10.1038\/sj.bjp.0706461"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(97)00078-5"},{"key":"3","unstructured":"3.Moskowitz MA: Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology1993; <b>43<\/b>: S16-S20."},{"issue":"1\/2","key":"4","first-page":"137","volume":"583","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8993","issn-type":"print"},{"issue":"2\/3","key":"5","first-page":"421","volume":"238","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6.May A, Goadsby PJ: Substance P receptor antagonists in the therapy of migraine. Expert Opin Investig Drugs2001; <b>10<\/b>: 673-678.","DOI":"10.1517\/13543784.10.4.673"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7.Arulmani U, Maassenvandenbrink A, Villalon CM, Saxena PR: Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol2004; <b>500<\/b>: 315-330.","DOI":"10.1016\/j.ejphar.2004.07.035"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8.Keller JT, Marfurt CF: Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol1991; <b>309<\/b>: 515-534.","DOI":"10.1002\/cne.903090408"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9.Edvinsson L, Goadsby PJ: Neuropeptides in the cerebral circulation: Relevance to headache. Cephalalgia1995; <b>15<\/b>: 272-276.","DOI":"10.1046\/j.1468-29821995.1504272.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10.Goadsby PJ, Edvinsson L: Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain1994; <b>117<\/b>: 427-434.","DOI":"10.1093\/brain\/117.3.427"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11.Ray BS, Wolff HG: Experimental studies on headache: Pain-sensitive structures of the head and their significance in headache. Arch Surg1940; <b>41<\/b>: 813-856.","DOI":"10.1001\/archsurg.1940.01210040002001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12.Jansen-Olesen I, Mortensen A, Edvinsson L: Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia1996; <b>16<\/b>: 310-316.","DOI":"10.1046\/j.1468-2982.1996.1605310.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13.Edvinsson L, Gulbenkian S, Barroso CP: Cunha e Sa, Polak JM, Mortensen A, Jorgensen L, Jansen-Olesen I. Innervation of the human middle meningeal artery: Immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides1998; <b>19<\/b>: 1213-1225.","DOI":"10.1016\/S0196-9781(98)00066-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14.Mes&beta;linger K, Hanesch U, Baumgartel M, Trost B, Schmidt RF: Innervation of the dura mater encephali of cat and rat: Ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol (Berl)1993; <b>188<\/b>: 219-237.","DOI":"10.1007\/BF00188214"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01012.x"},{"issue":"7","key":"16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1139\/y95-143","volume":"73","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0008-4212","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00366-2"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280213"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19.Edvinsson L, Ekman R, Jansen I, McCulloch J, Uddman R: Calcitonin gene-related peptide and cerebral blood vessels: Distribution and vasomotor effects. J Cereb Blood Flow Metab1987; <b>7<\/b>: 720-728.","DOI":"10.1038\/jcbfm.1987.126"},{"issue":"3","key":"20","first-page":"1020","volume":"257","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21.Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL: Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia1997; <b>17<\/b>: 518-524.","DOI":"10.1046\/j.1468-2982.1997.1704518.x"},{"issue":"7","key":"22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1476-5381.1995.tb13361.x","volume":"114","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1188","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23.Troltzsch M, Denekas T, Messlinger K: The Calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow. Eur J Pharmacol2007; <b>562<\/b>: 103-110.","DOI":"10.1016\/j.ejphar.2007.01.058"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.233"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25.Levy D, Strassman AM: Distinct sensitizing effects of the CAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol2002; <b>538<\/b>: 483-493.","DOI":"10.1113\/jphysiol.2001.013175"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20619"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27.Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K: Calcitonin receptor-like receptor (CLR), receptor activity modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution. J Comp Neurol2008; <b>507<\/b>: 1277-1299.","DOI":"10.1002\/cne.21607"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28.Dimlich RV, Keller JT, Strauss TA, Fritts MJ: Linear arrays of homogeneous mast cells in the dura mater of the rat. J Neurocytol1991; <b>20<\/b>: 485-503.","DOI":"10.1007\/BF01252276"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29.Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM: Mast cell degranulation activates a pain pathway underlying migraine headache. Pain2007; <b>130<\/b>: 166-176.","DOI":"10.1016\/j.pain.2007.03.012"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01321.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31.Segond v Banchet G, Pastor A, Biskup C, Schlegel C, Benndorf K, Schaible HG: Localization of functional calcitonin gene-related peptide binding sites in a subpopulation of cultured dorsal root ganglion neurons. Neuroscience2002; <b>110<\/b>: 131-145.","DOI":"10.1016\/S0306-4522(01)00547-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32.Zhang Z, Winborn CS: Marquez de PB, Russo AF. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci2007; <b>27<\/b>: 2693-2703.","DOI":"10.1523\/JNEUROSCI.4542-06.2007"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33.Li J, Vause CV, Durham PL: Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res2008; <b>1196<\/b>: 22-32.","DOI":"10.1016\/j.brainres.2007.12.028"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34.Fischer MJ, Koulchitsky S, Messlinger K: The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci2005; <b>25<\/b>: 5877-5883.","DOI":"10.1523\/JNEUROSCI.0869-05.2005"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35.Sixt ML, Messlinger K, Fischer MJ: Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain2009; <b>132<\/b>: 3134-3141.","DOI":"10.1093\/brain\/awp168"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36.Storer RJ, Akerman S, Goadsby PJ: Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol2004; <b>142<\/b>: 1171-1181.","DOI":"10.1038\/sj.bjp.0705807"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37.Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR, Lawrence GW, Dolly JO: Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci2009; <b>29<\/b>: 4981-4992.","DOI":"10.1523\/JNEUROSCI.5490-08.2009"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38.Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM: Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology2008; <b>70<\/b>: 1304-1312.","DOI":"10.1212\/01.WNL.0000286940.29755.61"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030505"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/60\/3\/60_3_82\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T02:11:04Z","timestamp":1656555064000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/kjm\/60\/3\/60_3_82\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.60.82","relation":{},"ISSN":["1880-1293","0022-9717"],"issn-type":[{"value":"1880-1293","type":"electronic"},{"value":"0022-9717","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}